Global Burden of Disease Cancer C. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019. JAMA Oncol. 2022;8:420–44.
NCRI. Cancer in Ireland 1994-2022 with estimates for 2020-2022: Annual report of the National Cancer Registry. 2024. Ireland: National Cancer Registry Ireland; 2024.
Joint Research Centre – EU Science – Ireland is the country with the highest cancer incidence in the EU [WWW Document]. 2020. https://ec.europa.eu/newsroom/eusciencehubnews/items/684847/en. Accessed 12.9.23
National Cancer Registry Ireland. Cancer in Ireland 1994-2018 with estimates for 2018-2020: Annual report of the National Cancer Registry. Ireland: National Cancer Registry Ireland; 2020.
Rubin G, Berendsen A, Crawford SM, Dommett R, Earle C, Emery J, et al. The expanding role of primary care in cancer control. Lancet Oncol. 2015;16:1231–72.
Canaway R, Boyle DI, Manski-Nankervis JE, Bell J, Hocking JS, Clarke K, et al. Gathering data for decisions: best practice use of primary care electronic records for research. Med J Aust. 2019;210:S12–6.
Liu F, Panagiotakos D. Real-world data: a brief review of the methods, applications, challenges and opportunities. BMC Med Res Methodol. 2022;22:287.
Dulaney C, Wallace AS, Everett AS, Dover L, McDonald A, Kropp L. Defining Health Across the Cancer Continuum. Cureus. 2017;9:e1029.
Charmsaz S, Doherty B, Cocchiglia S, Varešlija D, Marino A, Cosgrove N, et al. ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis. BMC Med. 2020;18:349.
David W, Usha M, Alina Zalounina F, Henry J, Andriana B, et al. Diagnostic routes and time intervals for patients with colorectal cancer in 10 international jurisdictions; findings from a cross-sectional study from the International Cancer Benchmarking Partnership (ICBP). BMJ Open. 2018;8:e023870.
Gunne E, McGarvey C, Hamilton K, Treacy E, Lambert DM, Lynch SA. A retrospective review of the contribution of rare diseases to paediatric mortality in Ireland. Orphanet J Rare Dis. 2020;15:311.
Foley J, Cronin M, Brent L, Lawrence T, Simms C, Gildea K, et al. Cycling related major trauma in Ireland. Injury. 2020;51:1158–63.
Dempsey S, Lyons S, Nolan A. High Radon Areas and lung cancer prevalence: evidence from Ireland. J Environ Radioact. 2018;182:12–9.
O’Sullivan K, O’Donovan A. Factors associated with breast cancer mammography screening and breast self-examination in Irish women: results from the Irish Longitudinal Study on Ageing (TILDA). Acta Oncologica. 2022;61:1301–8.
Connolly S, Whyte R. Uptake of cancer screening services among middle and older ages in Ireland: the role of healthcare eligibility. Public Health. 2019;173:42–7.
Burns R, Walsh B, Sharp L, O’Neill C. Prostate cancer screening practices in the Republic of Ireland: the determinants of uptake. J Health Serv Res Policy. 2012;17:206–11.
Hickey D, O’Connor R, McCormack P, Kearney P, Rosti R, Brennan R. The data quality index: improving data quality in Irish healthcare records. In: 24th International Conference Enterprise Information Systems (ICEIS ‘21). Orcid; SciTEPress: 2021.
Thompson S. Delay in rolling out electronic health records an ‘enormous missed opportunity’. The Irish Times; 2022.
O’Dowd EL, Ten Haaf K, Kaur J, Duffy SW, Hamilton W, Hubbard RB, et al. Selection of eligible participants for screening for lung cancer using primary care data. Thorax. 2022;77:882–90.
Imperiale TF. CRC screening with sigmoidoscopy extends life by 110 d; other cancer screening tests do not extend life. Ann Intern Med. 2024;177:Jc9.
Choi E, Ding VY, Luo SJ, Ten Haaf K, Wu JT, Aredo JV, et al. Risk model-based lung cancer screening and racial and ethnic disparities in the US. JAMA Oncol. 2023;9:1640–8.
Saini SD, Lewis CL, Kerr EA, Zikmund-Fisher BJ, Hawley ST, Forman JH, et al. Personalized multilevel intervention for improving appropriate use of colorectal cancer screening in older adults: a cluster randomized clinical trial. JAMA Intern Med. 2023;183:1334–42.
Mahashabde R, Bhatti SA, Martin BC, Painter JT, Rodriguez A, Ying J, et al. Real-world survival of first-line immune checkpoint inhibitor treatment versus chemotherapy in older patients with non-small-cell lung cancer and synchronous brain metastases. JCO Oncol Pr. 2023;19:1009–19.
Steliarova-Foucher E, O’Callaghan M, Ferlay J, Masuyer E, Rosso S, Forman D, et al. The European cancer observatory: a new data resource. Eur J Cancer. 2015;51:1131–43.
OFHOFHRP. Our future health research portal. 2025. https://research.ourfuturehealth.org.uk/.
Busingye D, Gianacas C, Pollack A, Chidwick K, Merrifield A, Norman S, et al. Data Resource Profile: MedicineInsight, an Australian national primary health care database. Int J Epidemiol. 2019;48:1741-h.
Roseleur J, Gonzalez-Chica DA, Emery J, Stocks NP. Skin checks and skin cancer diagnosis in Australian general practice before and during the COVID-19 pandemic, 2011-2020. Br J Dermatol. 2021;185:853–5.
Sollie A, Roskam J, Sijmons RH, Numans ME, Helsper CW. Do GPs know their patients with cancer? Assessing the quality of cancer registration in Dutch primary care: a cross-sectional validation study. BMJ Open. 2016;6:e012669.
Smeets HM, Kortekaas MF, Rutten FH, Bots ML, van der Kraan W, Daggelders G, et al. Routine primary care data for scientific research, quality of care programs and educational purposes: the Julius General Practitioners’ Network (JGPN). BMC Health Serv Res. 2018;18:735.
Garritty C, Gartlehner G, Nussbaumer-Streit B, King VJ, Hamel C, Kamel C, et al. Cochrane Rapid Reviews Methods Group offers evidence-informed guidance to conduct rapid reviews. J Clin Epidemiol. 2021;130:13–22.
Milne BJ, Atkinson J, Blakely T, Day H, Douwes J, Gibb S, et al. Data resource profile: the New Zealand integrated data infrastructure (IDI). Int J Epidemiol. 2019;48:677-e.
Aanestad M, Grisot M, Hanseth O, Vassilakopoulou P. Information infrastructures within European health care: Working with the installed base. Cham; Springer: 2017.
Herrett E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, Van Staa T, et al. Data resource profile: clinical practice research datalink (CPRD). Int J Epidemiol. 2015;44:827–36.
Emery J, Boyle D. Data linkage. Aust Fam Physician. 2017;46:615–9.
Michael W. Conference Handbook. International Health Data Linkage Conference. 2014. https://www.popdata.bc.ca/sites/default/files/documents/events/popdata/IHDLN_2014_Conference_Handbook.pdf.
Lee A, McCarthy D, Bergin RJ, Drosdowsky A, Martinez Gutierrez J, Kearney C, et al. Data resource profile: victorian comprehensive cancer centre data connect. Int J Epidemiol. 2023;52:e292–300.
Usha M, Peter V, Alina Zalounina F, Henry J, Samantha H, Irene R, et al. Time intervals and routes to diagnosis for lung cancer in 10 jurisdictions: cross-sectional study findings from the International Cancer Benchmarking Partnership (ICBP). BMJ Open. 2019;9:e025895.
Eastwood SV, Hughes AD, Tomlinson L, Mathur R, Smeeth L, Bhaskaran K, et al. Ethnic differences in hypertension management, medication use and blood pressure control in UK primary care, 2006-2019: a retrospective cohort study. Lancet Reg Health Eur. 2023;25:100557.
Fahmi A, Wong D, Walker L, Buchan I, Pirmohamed M, Sharma A, et al. Combinations of medicines in patients with polypharmacy aged 65-100 in primary care: large variability in risks of adverse drug related and emergency hospital admissions. PLoS One. 2023;18:e0281466.
Padmanabhan S, Carty L, Cameron E, Ghosh RE, Williams R, Strongman H. Approach to record linkage of primary care data from Clinical Practice Research Datalink to other health-related patient data: overview and implications. Eur J Epidemiol. 2019;34:91–9.
Koshiaris C, Van den Bruel A, Nicholson BD, Lay-Flurrie S, Hobbs FDR, Oke JL. Clinical prediction tools to identify patients at highest risk of myeloma in primary care: a retrospective open cohort study. Br J Gen Pract. 2021;71:e347.
Chima S, Reece JC, Milley K, Milton S, McIntosh JG, Emery JD. Decision support tools to improve cancer diagnostic decision making in primary care: a systematic review. Br J Gen Pract. 2019;69:e809.